Article Information
History
- December 16, 2021.
Article Versions
- You are currently viewing Version 1 of this article (December 16, 2021 - 00:08).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yegnasew Takele1,2,
- Tadele Mulaw2,
- Emebet Adem2,*,
- Rebecca Womersley1,
- Myrsini Kaforou1,
- Susanne Ursula Franssen3,**,
- Michael Levin1,
- Graham Philip Taylor1,
- Ingrid Müller1,
- James Anthony Cotton3 and
- Pascale Kropf1,#
- 1Department of Infectious Disease, Imperial College London, London, UK
- 2Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia
- 3Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
- ↵#Corresponding author, Pascale Kropf, Imperial College London Norfolk Place, W2 1PG, London, UK p.kropf{at}imperial.ac.uk Phone: +44 20 7594 17 55
Posted December 16, 2021.
HIV-1 co-infection increases relapse rate and shortens survival in patients with visceral leishmaniasis
